InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Whitley Richard James, Director. Insider active across 2 companies, notably Gilead Sciences INC. In total, 6 filings have been logged. Split: 3 buys · 1 sell. Total volume traded: €13k. Activity tracked since 3 May 2021. The latest transaction was disclosed on 8 December 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Whitley Richard James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
1,800 shares@ US$0.25911.9% of flowCommon StockSEC:0001415889-22-012370:0
500 shares@ US$4.5259.7% of flowCommon StockSEC:0001415889-22-005275:0
Canonical exit: 16 Aug 2022 (T+90)
1,800 shares@ US$5.7240.7% of flowCommon StockSEC:0001415889-22-000447:0
Canonical exit: 6 Apr 2022 (T+90)
200 shares@ US$5.7254.5% of flowCommon StockSEC:0001415889-21-006204:0
Canonical exit: 23 Mar 2022 (T+90)
1,936 sharesCommon StockSEC:0001127602-21-015952:0
20,282 shares@ US$20.645100.0% of flowCommon StockSEC:0001127602-21-015340:0
6 of 6 declarations
About Whitley Richard James
Richard James Whitley is a Board Member at Gilead Sciences Inc and Virios Therapeutics, Inc. He has significant experience in the biopharmaceutical sector. As a board member, he is involved in overseeing operations and strategic decision-making. His expertise in life sciences is valuable in guiding these companies towards sustainable growth.
